Wu, Bogang http://orcid.org/0000-0003-1654-198X
Zhang, Xiaowen
Chiang, Huai-Chin
Pan, Haihui
Yuan, Bin
Mitra, Payal
Qi, Leilei
Simonyan, Hayk
Young, Colin N.
Yvon, Eric
Hu, Yanfen
Zhang, Nu http://orcid.org/0000-0001-9695-210X
Li, Rong http://orcid.org/0000-0002-6471-6580
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (CA246707, CA220578)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 20 January 2022
Accepted: 31 March 2022
First Online: 20 April 2022
Competing interests
: R.L. and B.W. are co-inventors of a pending patent (application number 62/982,514) filed by The George Washington University on the therapeutic utility of NELFB in CAR-T therapy. The remaining authors declare no competing interests.